| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Pseudomonas aeruginosa (F66336) |
- |
- |
8 － ? |
Chloramphenicol (Chloromycetin)  |
955 |
| Pseudomonas aeruginosa (F66336) |
- |
- |
256 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
955 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
2 |
8 |
0.25 － >8 |
Gentamicin (Gentamycin, Garamycin) |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
2 |
8 |
0.5 － >8 |
Imipenem |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
2 |
16 |
0.5 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
8 |
32 |
1 － 32 |
ACH-702 |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
8 |
32 |
2 － 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-resistant) |
64 |
64 |
4 － 64 |
Moxifloxacin (BAY 12-8039, Avelox) |
1279 |
| Pseudomonas aeruginosa (fluoroquinolone-susceptible) |
- |
0.094 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
66 |
| Pseudomonas aeruginosa (fluoroquinolone-susceptible) |
- |
0.38 |
? － ? |
Gatifloxacin (Tequin) |
66 |
| Pseudomonas aeruginosa (fluoroquinolone-susceptible) |
- |
0.5 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
66 |
| Pseudomonas aeruginosa (fluoroquinolone-susceptible) |
- |
0.75 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
66 |
| Pseudomonas aeruginosa (fluoroquinolone-susceptible) |
- |
1.5 |
? － ? |
Ofloxacin (Floxin) |
66 |
| Pseudomonas aeruginosa (FP1380) |
- |
- |
0.5 － ? |
Imipenem |
206 |
| Pseudomonas aeruginosa (FP1380) |
- |
- |
>128 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
206 |
| Pseudomonas aeruginosa (from respiratory tract infection + from respiratory tract infect) |
0.12 |
0.5 |
0.008 － 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
0.5 |
2 |
0.03 － 16 |
Gemifloxacin |
268 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
0.5 |
2 |
0.06 － 4 |
Levofloxacin (Levaquin, Quixin) |
268 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
1 |
4 |
0.03 － 4 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
1 |
4 |
0.06 － 8 |
DC-159a |
268 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
1 |
4 |
0.12 － 16 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
0.12 |
0.5 |
0.06 － 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
0.5 |
2 |
0.06 － 4 |
Levofloxacin (Levaquin, Quixin) |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
0.5 |
2 |
0.25 － 4 |
Gemifloxacin |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
1 |
4 |
0.5 － 8 |
DC-159a |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
1 |
4 |
0.5 － 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Pseudomonas aeruginosa (from urinary tract infection + quinolone-susceptible) |
2 |
4 |
0.5 － 8 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Pseudomonas aeruginosa (GC 2214) |
- |
- |
<0.12 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
209 |